Association of ideal cardiovascular metrics and serum high-sensitivity C-reactive protein in hypertensive population

PLoS ONE

Volumn 8, Issue 12, 2013, Pages

  Xue, Hao ^a   Wang, Jianli ^b   Hou, Jinhong ^b   Zhu, Hang ^a   Gao, Jingsheng ^b   Chen, Shuohua ^b   Wang, Yutang ^a   Chen, Yundai ^a   Wu, Shouling ^b  

^a CHINESE PLA GENERAL HOSPITAL   (China)

^b HEBEI UNITED UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

C REACTIVE PROTEIN; CHOLESTEROL; GLUCOSE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; HIGH SENSITIVITY C REACTIVE PROTEIN; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL; UNCLASSIFIED DRUG;

AGE; ARTICLE; BLOOD ANALYSIS; BODY MASS; CARDIOVASCULAR FUNCTION; CARDIOVASCULAR PARAMETERS; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; CORRELATION ANALYSIS; CROSS-SECTIONAL STUDY; DIASTOLIC BLOOD PRESSURE; EMPLOYEE; EXERCISE; FEMALE; GENDER; GLUCOSE BLOOD LEVEL; HEALTH BEHAVIOR; HUMAN; HYPERTENSION; IDEAL CARDIOVASCULAR HEALTH BEHAVIOR; IDEAL CARDIOVASCULAR HEALTH FACTOR; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE LOGISTIC REGRESSION ANALYSIS; QUESTIONNAIRE; RISK FACTOR; SMOKING; SODIUM RESTRICTION; SYSTOLIC BLOOD PRESSURE;

ADULT; AGED; BIOLOGICAL MARKERS; BLOOD GLUCOSE; C-REACTIVE PROTEIN; CHOLESTEROL, HDL; CHOLESTEROL, LDL; CROSS-SECTIONAL STUDIES; FEMALE; HUMANS; HYPERTENSION; LOGISTIC MODELS; MALE; MIDDLE AGED; QUESTIONNAIRES; RISK FACTORS; TRIGLYCERIDES;

EID: 84892605736     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0081597     Document Type: Article

References (27)

1. Ministry of health of the people's Republic of China (2010) China Health Statistics Yearbook [M]. Peking Union Medical College press. 276: 315.
2. Lloyd-Jones DM, Hong Y, Labarthe D, Mozaffarian D, Appel LJ, et al. (2010) Defining and setting national goal for cardiovascular health promotion and disease reduction: The American heart association's strategic impact gola through 2020 and beyond. Circulation 121: 586-613.
3. Higashiyama A, Wakabayashi I, Kubota Y, Adachi Y, Hayashibe A, et al. (2012) Does high-sensitivity C-reactive protein or low-density lipoprotein cholesterol show a stronger relationship with the cardio-ankle vascular index in healthy community dwellers?: the KOBE study. J Atheroscler Thromb 19: 1027-34.
4. Shafi Dar M, Pandith AA, Sameer AS, Sultan M, Yousuf A, et al. (2010) hs-CRP: A potential marker for hypertension in Kashmiri population. Indian J Clin Biochem 25: 208-12.
5. Marques-Vidal P, Bochud M, Bastardot F, Lüscher T, Ferrero F, et al. (2012) Association between inflammatory and obesity markers in a Swiss populationbased sample (CoLaus Study). Obes Facts 5: 734-44.
6. Zhu Y, Zhang Y, Ling W, Feng D, Wei X, et al. (2011) Fruit consumptionis associated with lower carotid intima-media thicknessand C-reactive protein levels in patients with type 2 diabetesmellitus. J Am Diet Assoc 111: 1536-42.
7. Michigan A, Johnson TV, Master VA (2011) Review of the relationship between C-reactive protein and exercise. Mol Diagn Ther 15: 265-75.
8. Rojo-Martínez G, Soriguer F, Colomo N, Calle A, Goday A, et al. (2013) Factors determining high-sensitivity C-reactive protein values inthe Spanish population. Di@bet.es study. Eur J Clin Invest 43: 1-10.
9. Belfki H, Ben Ali S, Bougatef S, Ben Ahmed D, Haddad N, et al. (2012) Relationship of C-reactive protein with components of the metabolic syndrome in a Tunisian population. Eur J Intern Med 23: e5-9.
10. Lenfant C, Chobanian AV, Jones DW, Roccella EJ; Joint National Committee on the Prevention, Detection, Evaluation, and Treatment of High Blood Pressure (2003) Seventh report of the Joint National Committee on the Prevention, Detection, Evaluation, and Treatment of High Blood Pressure (JNC 7): resetting the hypertension sails. Hypertension 41: 1178-1179.
11. Pearson TA, Mensah GA, Alexander RW, Anderson JL, Cannon RO 3rd, et al. (2003) Markers of Inflammation and cardiovascular disease: application to clinical and Public Health practice: a statement for healthcare professionals from the centers for disease control and prevention and the American heart association. Circulation, 107: 499-511.
12. Wu S, Huang Z, Yang X, Zhou Y, Wang A, et al. (2012) Prevalence of ideal cardiovascular health and its relationship with the 4-year cardiovascular events in a northern Chinese industrial city. Circ Cardiovasc Qual Outcomes. 5: 487-493.
13. Wu S, Li Y, Jin C, Yang P, Li D, et al. (2012) Intra-individual variability of high-sensitivity C-reactive protein in Chinese general population. Int J Cardiol 157: 75-79.
14. Mitchell JA, Bornstein DB, Sui X, Hooker SP, Church TS, et al. (2010) The impact of combined health factors on cardiovascular disease mortality. Am Heart J 160: 102-108.
15. Odegaard AO, Koh WP, Gross MD, Yuan JM, Pereira MA (2011) Combined lifestyle factors and cardiovascular disease mortality in Chinese men and women: the Singapore Chinese health study. Circulation 124: 2847-2854.
16. Kvaavik E, Batty GD, Ursin G, Huxley R, Gale CR (2010) Influence of individual and combined health behaviors on total and cause-specific mortality in men and women: the United Kingdom Health and Lifestyle Survey. Arch Intern Med 170: 711-718.
17. Nechuta SJ, Shu XO, Li HL, Yang G, Xiang YB, et al. (2010) Combined impact of lifestyle-related factors on total and cause-specific mortality among Chinese women: prospective cohort study. PLoS Med 7: pii, e1000339.
18. Chuang SY, Hsu PF, Chang HY, Bai CH, Yeh WT, et al. (2013) C-reactive Protein Predicts Systolic Blood Pressure and Pulse Pressure but not Diastolic Blood Pressure: the Cardiovascular Disease Risk Factors Two-Township Study. Am J Hypertens 26: 657-64.
19. Hung J, Knuiman MW, Divitini ML, Davis T, Beilby JP (2008) Prevalence and risk factor correlates of elevated C-reactive protein in an adult Australian population. Am J Cardiol 101: 193-198.
20. Labonté ME, Dewailly E, Chateau-Degat ML, Couture P, Lamarche B (2012) Population-based study of high plasma C-reactive protein concentrations among the Inuit of Nunavik. Int J Circumpolar Health 71. [Epub 2012 Oct 17].
21. Rabkin SW, Langer A, Ur E, Calciu CD, Leiter LA (2013) Inflammatory biomarkers CRP, MCP-1, serum amyloid alpha and interleukin-18 in patients with HTN and dyslipidemia: impact of diabetes mellitus on metabolic syndrome and the effect of statin therapy. Hypertens Res 7. [Epub ahead of print].
22. Villegas R, Xiang YB, Cai H, Elasy T, Cai Q, et al. (2012) Lifestyle determinants of C-reactive protein in middle-aged, urban Chinese men. Nutr Metab Cardiovasc Dis 22: 223-230.
23. WenJ, Liang Y, Wang F, Sun L, Guo Y, et al. (2009) Association of C-reactive protein and metabolic syndrome in a rural Chinese population. Clin Biochem 42: 976-983.
24. Azadbakht L, Surkan PJ, Esmaillzadeh A, Willett WC (2011) The Dietary Approaches to Stop Hypertension Eating Plan Affects C-Reactive Protein, Coagulation Abnormalities, and Hepatic Function Tests among Type 2 Diabetic Patients. J Nutr 141: 1083-1088.
25. Cozma A, Orǎşan O, Sâmpelean D, Fodor A, Vlad C, et al. (2009) Endothelial dysfunction in metabolic syndrome. Rom J Intern Med 47: 133-40.
26. Kantor ED, Lampe JW, Kratz M, White E (2013) Lifestyle factors and inflammation: associations by body mass index. PLoS One 8: e67833.
27. Hotamisligil GS, Shargill NS, Spiegelman BM (1993) Adipose expression of tumor necrosis factor-alpha: direct role in obesity linked insulin resistance. Science 259: 87-91.